Successful anticoagulation for bilateral central retinal vein occlusions accompanied by cerebral venous thrombosis

Archives of Neurology

Volumn 63, Issue 11, 2006, Pages 1648-1651

  Young, Hoon Lee ^a   Joon, Young Lee ^a   Ye, Sung Kim ^a   Dae, Hyun Kim ^a   Kim, Jei ^a  

^a Chungnam National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; WARFARIN;

ADULT; ANAMNESIS; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; CLINICAL FEATURE; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HUMAN CELL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OPHTHALMOSCOPY; PRIORITY JOURNAL; TREATMENT RESPONSE; VISUAL ACUITY;

ADULT; ANTICOAGULANTS; CEREBRAL VEINS; HEPARIN; HUMANS; MALE; RETINAL VEIN OCCLUSION; TIME FACTORS; VENOUS THROMBOSIS; WARFARIN;

EID: 33751009370     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.11.1648     Document Type: Article

References (10)

1. Williamson TH. Central retinal vein occlusion: what's the story? Br J Ophthalmol. 1997;81:698-704.
2. Hayreh SS. Management of central retinal vein occlusion. Ophthalmologica. 2003;217:167-188.
3. Prisco D, Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb. 2002;32:308-311.
4. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE. Radial optic neurotomy for central retinal vein occlusion: 117 consecutive cases. Retina. 2006;26:297-305.
5. Casares PZ, Gillet DS, Verity DH, Rowson NR. Bilateral simultaneous central retinal vein occlusion (CRVO) caused by waldenstrom's macroglobulinaemia with acquired von willebrand's disease. Br J Haematol. 2002;118:344-347.
6. Aggio FB, Cariello AJ, Almeida MS, et al. Bilateral central retinal vein occlusion associated with multiple myeloma. Ophthalmologica. 2004;218:283-287.
7. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352:1791-1798.
8. Weitz JI. Low-molecular-weight heparins. N Engl J Med. 1997;337:688-698.
9. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484-488.
10. Kim JS, Jeong SH, Kim DH, Kim J. Safety and feasibility of subcutaneous low molecular weight heparin for cerebral venous sinus thrombosis. J Clin Neurol. 2005;1:134-141.